1
|
Lv S, Yang N, Lu Y, Zhang G, Zhong X, Cui Y, Huang Y, Teng J, Sai Y. The therapeutic potential of traditional Chinese medicine in depression: focused on the modulation of neuroplasticity. Front Pharmacol 2024; 15:1426769. [PMID: 39253375 PMCID: PMC11381291 DOI: 10.3389/fphar.2024.1426769] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/03/2024] [Accepted: 08/06/2024] [Indexed: 09/11/2024] Open
Abstract
Depression, a mood disorder characterized by a persistent low mood and lack of enjoyment, is considered the leading cause of non-fatal health losses worldwide. Neuroplasticity refers to the brain's ability to adapt to external or internal stimuli, resulting in functional and structural changes. This process plays a crucial role in the development of depression. Traditional Chinese Medicine (TCM) shows significant potential as a complementary and alternative therapy for neurological diseases, including depression. However, there has been no systematic summary of the role of neuroplasticity in the pathological development of depression and TCM Interventions currently. This review systematically summarized recent literature on changes in neuroplasticity in depression and analyzed the regulatory mechanisms of active metabolites in TCM and TCM formulas on neuroplasticity in antidepressant treatment. Additionally, this review discussed the limitations of current research and the application prospects of TCM in regulating neuroplasticity in antidepressant research.
Collapse
Affiliation(s)
- Shimeng Lv
- Department of First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, China
| | - Ni Yang
- Department of First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, China
| | - Yitong Lu
- Department of First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, China
| | - Guangheng Zhang
- Department of First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, China
| | - Xia Zhong
- Institute of Child and Adolescent Health, School of Public Health, Peking University, Beijing, China
| | - Yaru Cui
- Innovative Institute of Chinese Medicine and Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, China
| | - Yufei Huang
- Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China
| | - Jing Teng
- Department of First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, China
| | - Yanyan Sai
- University Town Hospital, Afiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China
| |
Collapse
|
2
|
Wang W, Wang Y, Guo Q, Li H, Wang Z, Li J, Li T, Tang T, Wang Y, Jia Y, Wang Y, Zou J, Shi Y, Guo D, Yang M, Zhang X, Sun J. Valerian essential oil for treating insomnia via the serotonergic synapse pathway. Front Nutr 2022; 9:927434. [PMID: 35990355 PMCID: PMC9387164 DOI: 10.3389/fnut.2022.927434] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2022] [Accepted: 07/04/2022] [Indexed: 11/13/2022] Open
Abstract
Valerian volatile oil can be used in the treatment of insomnia; however, the active components and mechanisms of action are currently unclear. Therefore, we used transcriptome sequencing and weight coefficient network pharmacology to predict the effective components and mechanism of action of valerian volatile oil in an insomnia model induced by intraperitoneal injection of para-Chlorophenylalanine (PCPA) in SD rats. Valerian essential oil was given orally for treatment and the contents of 5-hydroxytryptamine receptor 1 A (5-HT1AR), γ-aminobutyric acid (GABA), cyclic adenosine monophosphate (cAMP), and protein kinase A (PKA) in the hippocampus of rats in each group were detected by enzyme-linked immunosorbent assay (ELISA), western blot, Polymerase Chain Reaction (PCR), and immunohistochemistry. The results showed that after treatment with valerian essential oil, insomnia rats showed significantly prolonged sleep duration and alleviated insomnia-induced tension and anxiety. Regarding the mechanism of action, we believe that caryophyllene in valerian essential oil upregulates the 5-HT1AR receptor to improve the activity or affinity of the central transmitter 5-HT, increase the release of 5-HT, couple 5-HT with a G protein coupled receptor, convert adenosine triphosphate (ATP) into cAMP (catalyzed by ADCY5), and then directly regulate the downstream pathway. Following pathway activation, we propose that the core gene protein kinase PKA activates the serotonergic synapse signal pathway to increase the expression of 5-HT and GABA, thus improving insomnia symptoms and alleviating anxiety. This study provides a theoretical basis for the application of valerian volatile oil in health food.
Collapse
Affiliation(s)
- Wenfei Wang
- Key Laboratory of Basic and New Drug Research of Traditional Chinese Medicine, College of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, China
| | - Yichun Wang
- School of Pharmaceutical Sciences, College of Pharmacy, Kyushu University, Fukuoka, Japan
| | - Qiuting Guo
- Xianyang Vocational Technical College, College of Pharmacy, Xianyang, China
| | - Huiting Li
- Key Laboratory of Basic and New Drug Research of Traditional Chinese Medicine, College of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, China
- Key Laboratory of Modern Preparation of TCM, Ministry of Education, College of Pharmacy, Jiangxi University of Chinese Medicine, Nanchang, China
| | - Zhaoqiang Wang
- Shaanxi Haitian Pharmaceutical Co., Ltd., Xianyang, China
| | - Jia Li
- Key Laboratory of Basic and New Drug Research of Traditional Chinese Medicine, College of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, China
| | - Taotao Li
- Key Laboratory of Basic and New Drug Research of Traditional Chinese Medicine, College of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, China
| | - Tiantian Tang
- Key Laboratory of Basic and New Drug Research of Traditional Chinese Medicine, College of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, China
| | - Yujiao Wang
- Key Laboratory of Basic and New Drug Research of Traditional Chinese Medicine, College of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, China
| | - Yanzhuo Jia
- Key Laboratory of Basic and New Drug Research of Traditional Chinese Medicine, College of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, China
| | - Yao Wang
- Key Laboratory of Basic and New Drug Research of Traditional Chinese Medicine, College of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, China
| | - Junbo Zou
- Key Laboratory of Basic and New Drug Research of Traditional Chinese Medicine, College of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, China
| | - Yajun Shi
- Key Laboratory of Basic and New Drug Research of Traditional Chinese Medicine, College of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, China
| | - Dongyan Guo
- Key Laboratory of Basic and New Drug Research of Traditional Chinese Medicine, College of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, China
| | - Ming Yang
- Xianyang Vocational Technical College, College of Pharmacy, Xianyang, China
| | - Xiaofei Zhang
- Key Laboratory of Basic and New Drug Research of Traditional Chinese Medicine, College of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, China
- Key Laboratory of Modern Preparation of TCM, Ministry of Education, College of Pharmacy, Jiangxi University of Chinese Medicine, Nanchang, China
| | - Jing Sun
- Key Laboratory of Basic and New Drug Research of Traditional Chinese Medicine, College of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, China
| |
Collapse
|